Proprietary Algorithms for Polygenic Risk: Protecting Scientific Innovation or Hiding the Lack of It?

Direct-to-consumer genetic testing companies aim to predict the risks of complex diseases using proprietary algorithms. Companies keep algorithms as trade secrets for competitive advantage, but a market that thrives on the premise that customers can make their own decisions about genetic testing sho...

Descripción completa

Detalles Bibliográficos
Autor principal: Janssens, A. Cecile J.W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627729/
https://www.ncbi.nlm.nih.gov/pubmed/31200546
http://dx.doi.org/10.3390/genes10060448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627729/
https://www.ncbi.nlm.nih.gov/pubmed/31200546
http://dx.doi.org/10.3390/genes10060448

Ejemplares similares